Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherap. LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.65p +3.27% 20.50p 787,205 15:47:46
Bid Price Offer Price High Price Low Price Open Price
20.00p 21.00p 21.75p 19.85p 19.85p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -0.69 -1.11 24.3

Skinbiotherap. (SBTX) Latest News

More Skinbiotherap. News
Skinbiotherap. Takeover Rumours

Skinbiotherap. (SBTX) Share Charts

1 Year Skinbiotherap. Chart

1 Year Skinbiotherap. Chart

1 Month Skinbiotherap. Chart

1 Month Skinbiotherap. Chart

Intraday Skinbiotherap. Chart

Intraday Skinbiotherap. Chart

Skinbiotherap. (SBTX) Discussions and Chat

Skinbiotherap. (SBTX) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Skinbiotherap. trades in real-time

Skinbiotherap. (SBTX) Top Chat Posts

DateSubject
18/8/2018
09:20
Skinbiotherap. Daily Update: Skinbiotherap. is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherap. was 19.85p.
Skinbiotherap. has a 4 week average price of 15.50p and a 12 week average price of 12.75p.
The 1 year high share price is 29.50p while the 1 year low share price is currently 7.35p.
There are currently 118,708,494 shares in issue and the average daily traded volume is 1,122,472 shares. The market capitalisation of Skinbiotherap. is £24,335,241.27.
16/8/2018
14:58
mshilos: SBTX going below 20 p today and lower in the comings for reasons I explained in an earlier post below. In addition OPTI is now below £1 ...reason is as below : There is HUGE positive sentiment for OPTI and share price has soared recently on the back of this , but nothing more, no profit no HUGE contracts to report, no major news, etc, and NO PROFITS to report. They do have MASSIVE potential, if their LT plans are executed according to plan and they do have a great Founder/CEO. However, as a LT holder myself, since 27p I would expect the share price to fall to the 50-60 p levels before 2019 BUT to climb to over £2 in the next 2 years , if we keep moving in the right direction. It is only sentiment that is driven this share price at present, not profit, as there is no profit.IMO DYOR.
16/8/2018
14:07
mshilos: DROPPING TO SUB 19 p, here comes the drop ...reason is , it is fact that no trials can commence, without a stable formulation to apply on the clinical trial volunteers.It is simple, look up clinical trial regulations, they would be breaking the law. There will be another RNS before SEPT to announce the delay in the trial start date , unless, miraculously, they reformulate the compound to arrive at a stable formulation, beyond the current 24hrs. I hate to be a prophet of doom ( as I am both an OPTI and SBTX long term holder), but I expect the share price to fall even more than it has today, bacK well under 19p in IMHO and DYOR.
16/8/2018
13:06
mshilos: John in reply : I stand by my opinion that the clinical trial will now have to be delayed and there will need to be an RNS to confirm this once they know when it will take place. The share price will fall to the initial April 2017 price or lower until we have trial results. This is still in its infancy and far far away from a profit generating business but the potential is huge hence the recent share price price rise based on sentiment and potential alone. This RNS is not good news...it will drop more ...IMO. DYOR.
14/8/2018
10:07
2telfer: This is ground breaking science being developed at Manchester university and has huge potential. The application of their findings in tackling a wide range of conditions, improving and saving lives should not be underestimated. SBTX is such an exciting company which I'm invested in not just for the share price [ though thats nice] but for what it represents ; British science making a world wide impact.
09/8/2018
09:23
bdog51: SBTX price seems to follow that of OPTI. Today OPTI is down because TW told his loyal HSR followers to top slice, hence somehow SBTX seems to have followed. Odd logic, I know!
02/8/2018
12:43
rafboy: Certainly think there is a company or two keeping a very close eye on SBTX. In 6 months the share price is likely to be 2 or 3 times the current share price assuming the human skin trials are a success. However, we have anecdotal evidence showing that the team at SBTX are currently using the cream. We also know it has been tested on human skin in the lab. I believe the likelihood is that the human skin trials will be a success and that a deal will follow on fairly quickly. Just my personal view.
28/7/2018
17:00
speccy1: The more I think about it, the more sense it makes to place the OPTI held shares with an institutional investor and pay a cash divi. If the sale includes a lock-in period, it not only safeguards the SBTX share price, but given many of the OPTI investors would use their divi to buy SBTX, it could significantly improve the share price. The problem could then be everyone fighting to spend their divi at once and a mass charge causing a short term spike. It would be a terrible dilemma whether to buy straight away or hang fire until the initial rush for shares has died down. First World problems :)
27/7/2018
01:41
elrico: Speccy - I have every sympathy with your view. I would much prefer my in-specie be paid in SBTX shares because cash would feel the lesser value if SBTX share were the preferred option. That said, who is to say post divi SBTX shares were not a little depressed, would you not be in a position to buy more with your cash divi? Time will.
21/4/2018
21:46
onedayrodders: I posted this on OPTI board but will be of interest here .. Hey all, myself and Trotters were at the UK Investor show today and were chatting with SOH for quite a while.. I'm sure Trotters will be posting a few nuggets later but I know the SBTX divi is an Important issue many have asked about so here is what he said. They are absolutely aware and focused on making this as fair as possible by not allowing short term traders to benefit or damage either OPTI or SBTX share price. Options being discussed ... 1. Lock in period - Unlikely as regulators do not like this type of arrangement and view it as restricting the market. 2. Staggered benefit, for example, OPTI will give shareholders say 1000 SBTX shares and promise another 1000 shares the next year providing the first 1000 shares have not been sold. 3. Take advantage of increasing interest in Skinbiotix by selling a % of OPTI's stake in SBTX to by Institutional investors and delivering a SBTX cash divi. (Therefore delivering the SBTX divi promise, adding long term Institutional shareholders and removing volatility in the share price - my take) The qualifying for any divi, either shares or cash will be controlled by a record date and that cannot be a date in the past and will be from close of business on the day the divi details are announced. So they will be looking to time that towards the end of the day to allow the smallest window possible for the AIM trading vultures (my words not his !) That's from memory so hope I got it right (Trotters..correct me if I'm wrong) ODR
15/2/2018
15:19
incanus: It is normal for a company share price to rise in anticipation of a divi just as it is normal for the share price to depreciate by about the same amount ex divi. SBTX may decline more significantly if there is no locked shares. Naivety is astonishing. Let us hope management in both companies have some substance to shore up both shares.
Skinbiotherap. share price data is direct from the London Stock Exchange
add chat code
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180818 18:43:10